PRIVIA HEALTH GROUP INC (PRVA) Stock Analyst Earnings Estimates
NASDAQ:PRVA - Nasdaq - US74276R1023 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.357B 40.42% | 1.658B 22.19% | 1.736B 4.74% | 3.307B 90.45% | 3.655B 10.52% | 4.121B 12.75% | 2.682B -34.92% | 2.99B 11.48% | 3.536B 18.26% | 2.977B -15.81% | |
| EBITDA YoY % growth | -14.53M 93.24% | 27.182M 287.08% | 24.25M -10.79% | 111.48M 359.71% | 132.7M 19.03% | 158.65M 19.56% | 188.29M 18.68% | 218.89M 16.25% | 251.63M 14.96% | 286.62M 13.91% | |
| EBIT YoY % growth | -19.1M 91.21% | 20.649M 208.11% | 16.982M -17.76% | 37.211M 119.12% | 69.766M 87.49% | 101.77M 45.87% | 117.3M 15.26% | 150.5M 28.30% | 168.61M 12.03% | 202.16M 19.90% | |
| Operating Margin | -1.41% | 1.25% | 0.98% | 1.13% | 1.91% | 2.47% | 4.37% | 5.03% | 4.77% | 6.79% | |
| EPS YoY % growth | 0.13 107.14% | 0.19 46.15% | 0.11 -42.11% | 0.21 90.75% | 0.34 62.51% | 0.47 38.46% | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.05 78.91% | 0.06 100.60% | 0.07 139.36% | 0.09 370.47% | 0.11 113.32% | 0.09 57.20% |
| Revenue Q2Q % growth | 776.65M 4.97% | 782.67M -1.24% | 888.39M 11.24% | 884.17M 2.46% | 891.79M 14.83% | 895.73M 14.45% |
| EBITDA Q2Q % growth | 27.934M 148.32% | 29.614M 136.61% | 31.672M 344.89% | 32.349M 313.67% | 34.465M 23.38% | 31.355M 5.88% |
| EBIT Q2Q % growth | 9.739M 67.54% | 14.087M 168.43% | 13.19M 152.78% | 13.059M 291.46% | 15.371M 57.83% | 11.604M -17.63% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.02 -33.33% | 0.05 | -0.03 | -60.96% |
| Q1 2025 Q2Q % growth | 0.03 50.00% | 0.05 | -0.02 | -37.83% |
| Q4 2024 Q2Q % growth | 0.03 50.00% | 0.05 | -0.02 | -40.79% |
| Q3 2024 Q2Q % growth | 0.03 -40.00% | 0.05 | -0.02 | -38.73% |
| Q2 2024 Q2Q % growth | 0.03 -50.00% | 0.05 | -0.02 | -36.27% |
| Q1 2024 Q2Q % growth | 0.02 -66.67% | 0.05 | -0.03 | -58.84% |
| Q4 2023 Q2Q % growth | 0.02 -85.71% | 0.04 | -0.02 | -53.66% |
| Q3 2023 Q2Q % growth | 0.05 400.00% | 0.05 | 0.00 | -1.96% |
| Q2 2023 Q2Q % growth | 0.06 -57.14% | 0.06 | 0.00 | 5.32% |
| Q1 2023 Q2Q % growth | 0.06 137.50% | 0.02 | 0.04 | 222.32% |
| Q4 2022 Q2Q % growth | 0.14 227.27% | -0.03 | 0.17 | 596.58% |
| Q3 2022 Q2Q % growth | 0.01 111.11% | 0.00 | 0.01 | 105.10% |
| Q2 2022 Q2Q % growth | 0.14 108.33% | -0.03 | 0.17 | 625.68% |
| Q1 2022 Q2Q % growth | -0.16 -366.67% | -0.04 | -0.12 | -331.77% |
| Q4 2021 Q2Q % growth | -0.11 | -0.14 | 0.03 | 19.35% |
| Q3 2021 Q2Q % growth | -0.09 | -0.11 | 0.02 | 18.52% |
| Q2 2021 Q2Q % growth | -1.68 | -1.72 | 0.04 | 2.54% |
| Q1 2021 Q2Q % growth | 0.06 | 0.04 | 0.02 | 34.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 862.9M 18.53% | 816.11M | 46.79M | 5.73% |
| Q1 2025 Q2Q % growth | 798.6M 12.84% | 792.62M | 5.98M | 0.75% |
| Q4 2024 Q2Q % growth | 792.5M 4.74% | 734.37M | 58.13M | 7.92% |
| Q3 2024 Q2Q % growth | 739.9M 2.27% | 729.08M | 10.82M | 1.48% |
| Q2 2024 Q2Q % growth | 728M 4.00% | 720.57M | 7.43M | 1.03% |
| Q1 2024 Q2Q % growth | 707.7M 7.41% | 667.44M | 40.26M | 6.03% |
| Q4 2023 Q2Q % growth | 756.6M 107.63% | 739.91M | 16.69M | 2.26% |
| Q3 2023 Q2Q % growth | 723.5M 110.99% | 716.51M | 6.99M | 0.98% |
| Q2 2023 Q2Q % growth | 700M 108.64% | 699.7M | 300K | 0.04% |
| Q1 2023 Q2Q % growth | 658.9M 109.97% | 666.03M | -7.13M | -1.07% |
| Q4 2022 Q2Q % growth | 364.4M 32.36% | 598.88M | -234.48M | -39.15% |
| Q3 2022 Q2Q % growth | 342.9M 36.34% | 541.28M | -198.38M | -36.65% |
| Q2 2022 Q2Q % growth | 335.5M 48.58% | 533.59M | -198.09M | -37.12% |
| Q1 2022 Q2Q % growth | 313.8M 46.91% | 521.87M | -208.07M | -39.87% |
| Q4 2021 Q2Q % growth | 275.3M 28.83% | 426.82M | -151.52M | -35.50% |
| Q3 2021 Q2Q % growth | 251.5M 21.38% | 237.27M | 14.23M | 6.00% |
| Q2 2021 Q2Q % growth | 225.8M 23.19% | 219.32M | 6.48M | 2.95% |
| Q1 2021 Q2Q % growth | 213.6M 0.33% | 201.27M | 12.33M | 6.13% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.24% | -20.42% | 0% | -16.83% |
| Revenue | 0% | -0.9% | 0% | 0.79% |